Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00359
|
|||||
| Drug Name |
Lusutrombopag
|
|||||
| Synonyms |
(S,E)-3-(2,6-Dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylic acid; 2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-, (2E)-; LUSUTROMBOPAG; Lusutrombopag [USAN:INN]; mulpleta
|
|||||
| Therapeutic Class |
Thrombopoietin receptor agonist
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C29H32Cl2N2O5S
|
|||||
| Canonical SMILES |
CCCCCCOC(C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(C(=C3)Cl)C=C(C)C(=O)O)Cl
|
|||||
| InChI |
InChI=1S/C29H32Cl2N2O5S/c1-5-6-7-8-12-38-18(3)20-10-9-11-21(26(20)37-4)25-16-39-29(32-25)33-27(34)19-14-23(30)22(24(31)15-19)13-17(2)28(35)36/h9-11,13-16,18H,5-8,12H2,1-4H3,(H,35,36)(H,32,33,34)/b17-13+/t18-/m0/s1
|
|||||
| InChIKey |
NOZIJMHMKORZBA-KJCUYJGMSA-N
|
|||||
| CAS Number |
CAS 1110766-97-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 591.5 | Topological Polar Surface Area | 126 | ||
| Heavy Atom Count | 39 | Rotatable Bond Count | 13 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
7.7
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:136051
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.